Pages that link to "Q38318574"

The following pages link to Albert Giralt (Q38318574):

Displaying 47 items.

• Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine (Q27317185) (← links)
• Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity (Q28239309) (← links)
• Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons (Q33588405) (← links)
• Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3. (Q33894042) (← links)
• Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease (Q34989074) (← links)
• Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction (Q35487248) (← links)
• Cryostat Slice Irregularities May Introduce Bias in Tissue Thickness Estimation: Relevance for Cell Counting Methods. (Q35691116) (← links)
• A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease (Q36331582) (← links)
• DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neurons (Q36361852) (← links)
• Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies. (Q36809523) (← links)
• Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms (Q38234072) (← links)
• Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. (Q38290349) (← links)
• Acute drug-induced spine changes in the nucleus accumbens are dependent on β-adducin. (Q39536465) (← links)
• PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum. (Q39800916) (← links)
• BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. (Q39932912) (← links)
• Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease (Q40808235) (← links)
• Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility. (Q41867772) (← links)
• Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease. (Q41964090) (← links)
• Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction (Q42194515) (← links)
• Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model (Q42220275) (← links)
• Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity. (Q43280390) (← links)
• Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study (Q43288722) (← links)
• Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. (Q45288581) (← links)
• PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model (Q45292704) (← links)
• Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease (Q45295696) (← links)
• Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease (Q45303900) (← links)
• Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. (Q45305295) (← links)
• Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease (Q45306525) (← links)
• Age-dependent decline of motor neocortex but not hippocampal performance in heterozygous BDNF mice correlates with a decrease of cortical PSD-95 but an increase of hippocampal TrkB levels. (Q45729489) (← links)
• Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression (Q46176355) (← links)
• Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling (Q46863136) (← links)
• Age-related changes in STriatal-Enriched protein tyrosine Phosphatase levels: Regulation by BDNF. (Q47419575) (← links)
• The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice. (Q47825936) (← links)
• Neurobehavioral characterization of Endonuclease G knockout mice reveals a new putative molecular player in the regulation of anxiety (Q47895500) (← links)
• Dissociation between CA3-CA1 synaptic plasticity and associative learning in TgNTRK3 transgenic mice. (Q48257738) (← links)
• Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats (Q48903579) (← links)
• Pyk2 is essential for astrocytes mobility following brain lesion (Q49155354) (← links)
• 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway (Q50206457) (← links)
• Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity. (Q50437141) (← links)
• Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice. (Q54978077) (← links)
• PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease. (Q54978097) (← links)
• Pyk2 in the amygdala modulates chronic stress sequelae via PSD-95-related micro-structural changes (Q61448543) (← links)
• PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions. (Q64912402) (← links)
• Helios modulates the maturation of a CA1 neuronal subpopulation required for spatial memory formation (Q91232850) (← links)
• Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease (Q91282864) (← links)
• Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens (Q91800531) (← links)
• Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy (Q96126372) (← links)